Chemical structure of molecule TAK-981 Subasumstat

mechanism-based SAE E1 ligase inhibitor

first-in-class, Ph. II (IV) for adv. solid tumors

from phenotypic screen and scaffold hop

J. Med. Chem., Feb. 25, 2021

Millenium/Takeda, Cambridge, MA

5. The Millenium/Takeda SUMO-activating enzyme (SAE) inhibitor TAK-981 is a mechanism-based inhibitor that covalently forms a SUMO substrate-inhibitor adduct that potently inhibits SAE, rather than reacting with SAE directly.…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.